Halozyme and Genentech to Collaborate on Clinical Cancer Trials
Halozyme Therapeutics Inc. has partnered with Genentech to conduct clinical studies to evaluate Halozyme’s investigational drug PEGPH20 in six tumor types, starting... Read More
Day
December 1, 2016